Clinical Grade Lyophilized Peptides
GMP-certified lyophilized peptide products for clinical and commercial use — manufactured under controlled aseptic conditions with full batch documentation and Certificate of Analysis.
Precision Lyophilization for Peptide Stability
MayMag Biologics produces clinical-grade lyophilized peptides using validated freeze-drying processes that preserve peptide integrity, potency, and sterility. Our lyophilization capabilities support both development-scale and commercial-scale production, with full ICH-compliant stability data and regulatory documentation.
Download Clinical Grade Lyophilized Peptides Datasheet (PDF)Lyophilization Capabilities
Aseptic Lyophilization
Validated freeze-drying cycles under ISO 5 aseptic conditions for sterile peptide vials, ensuring product integrity and extended shelf life.
Vial & Stopper Compatibility
Compatibility testing for Type I glass vials, rubber stoppers, and aluminum crimp seals to ensure container closure integrity.
Stability Studies
ICH Q1A-compliant accelerated and long-term stability studies for lyophilized peptide products, supporting regulatory submissions.
Reconstitution Validation
Validated reconstitution procedures with bacteriostatic water or sterile diluents, with documented reconstitution time and clarity testing.
Batch Documentation & CoA
Full batch records, Certificate of Analysis, sterility testing (USP 71), endotoxin testing (LAL), and potency assay for every lot.
Clinical & Commercial Scale
Scalable lyophilization capacity from Phase I clinical batches through commercial production, with technology transfer support.
Lyophilized Peptide Portfolio
| Product | Form | Purity | Storage | Description |
|---|---|---|---|---|
| Tirzepatide Analogue | Lyophilized vial | ≥98% | -20°C | GLP-1/GIP dual agonist lyophilized for reconstitution. Clinical and commercial supply. |
| Semaglutide Analogue | Lyophilized vial | ≥98% | -20°C | GLP-1 receptor agonist lyophilized peptide for sterile reconstitution. |
| BPC-157 | Lyophilized vial | ≥98% | -20°C | Tissue repair pentadecapeptide in lyophilized sterile vial format. |
| Thymosin Beta-4 (TB-500) | Lyophilized vial | ≥98% | -20°C | Actin-binding regenerative peptide in lyophilized sterile vial format. |
| Cagrilitide | Lyophilized vial | ≥97% | -20°C | Amylin analogue lyophilized peptide for metabolic disorder research. |
| Custom Peptide Sequences | Lyophilized vial | ≥95–99% (per spec) | Per stability data | Custom GMP peptide synthesis and lyophilization for client-specified sequences. |
Request Lyophilized Peptide Specifications
Contact our team for lyophilization capacity, batch documentation requirements, stability data, and clinical supply agreements.
Request Lyophilized Peptide Info